Headquartered in South Boston, VA·Fiscal year ends June·NASDAQ: IPX·iperionx.com
About IPERIONX
IperionX Limited is an Australian-incorporated, U.S.-listed titanium metal and critical materials company developing a fully integrated, domestic American titanium supply chain. The company uses its patented HAMR™ (hydrogen-assisted metallothermic reduction) and HSPT™ (hydrogen sintering and phase transformation) technologies to produce high-performance titanium alloys from both recycled titanium scrap and titanium minerals at lower energy consumption, cost, and carbon emissions compared to the legacy Kroll process. IperionX operates a Titanium Manufacturing Campus in Halifax County, Virginia, where it produces titanium powder and near-net-shape titanium components for defense, aerospace, consumer electronics, automotive, medical, additive manufacturing, and industrial applications. The company also owns the Titan Critical Minerals Project in Tennessee — one of the largest titanium, rare earth, and zircon mineral sand resources in North America — which is fully permitted and progressing toward a Definitive Feasibility Study. An R&D center in Salt Lake City, Utah, supports ongoing technology development. IperionX holds exclusive commercial licensing rights to more than 40 global patents through the University of Utah. The company has received approximately US$59.8 million in U.S. government funding through Defense Production Act and IBAS programs and holds a US$99 million SBIR Phase III IDIQ contract for defense titanium supply. IperionX's ordinary shares trade on the ASX, and its American Depositary Shares (each representing 10 ordinary shares) trade on the Nasdaq Capital Market, both under the symbol 'IPX'. Updated
America’s rare earths problem is often framed as a mining problem. Dan Dreyfus, founder of Borneite Capital, argues that’s the wrong way to look at it because the United States has access…
IperionX Limited is an Australian-incorporated, U.S.-listed titanium metal and critical materials company developing a fully integrated, domestic American titanium supply chain.
What is the IPX stock price target?
The Wall Street consensus 12-month price target for IPX is $42.50.